All In MedTech

Device Trial Radar · NCT01526811

Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)

Post-market Study on Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

180

Actual

Start

Mar 2012

Primary completion

Dec 21, 2018

Study completion Dec 21, 2018

Sponsor

Lead sponsor
MedtronicPublic (MDT)
Sponsor type
Industry
First posted
Feb 6, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the benefits of endovascular repair with Endurant Stent Graft System by documenting overall mortality, complications, the rate of conversion to open surgical repair, and the development and rupture of the aneurysm on a long term, i.e. at 5 years, in a cohort of patients representative of the population treated under real-life conditions of use in France.

Conditions

  • Aneurysm
  • Aortic Aneurysm
  • Aortic Aneurysm, Abdominal
  • Vascular Diseases
  • Cardiovascular Diseases
  • Aortic Diseases

Interventions

  • Endurant Stent graftDevice

    Endurant Stent graft implantation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause mortalityTime frame: through 5 years

6 more outcomes with a free account

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Centre Hospitalier d'Avignon

    Avignon, France

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.